Beaumont Hospital, Royal Oak offers a 12 month Infectious Diseases PGY2 Residency program for one residency candidate. Our program strives to meet the needs of the resident based on previous PGY1 residency experience, interests and individual goals.
The PGY2 Infectious Diseases Residency at Beaumont Hospital, Royal Oak provides the resident with training in diverse areas of infectious disease from four experienced clinical infectious disease pharmacists. The resident will rotate through a number of core and elective rotations that serve to develop leadership skills and clinical expertise in Infectious Diseases pharmacotherapy. Participation in interdisciplinary committees, interactions with other healthcare providers, along with formal and informal presentations, will help strengthen the resident’s communication skills. The resident will gain teaching experience through student and resident preceptorship and didactic instruction
The PGY2 Infectious Diseases Residency Program can be structurally divided into 3 components; individual learning experiences (each one month in duration, unless otherwise specified), longitudinal requirements, and weekend staffing. Our program strives to maximize individual growth and development during the year through the use of our advisor program. Opportunities for leadership development are imbedded into the program. The PGY2 ID resident will complete 10 required learning experiences, 6 required longitudinal learning experiences and 2 elective learning experiences.
Beaumont Hospital, Royal Oak employs 20 Clinical Pharmacy Specialists, the majority of whom hold adjunct faculty appointments with neighboring Colleges of Pharmacy (Wayne State University and the University of Michigan) and the Oakland University William Beaumont School of Medicine. The Department of Pharmacy at Beaumont Hospital, Royal Oak has 7 residency programs as follows: PGY1 Pharmacy, PGY1 Non-traditional Pharmacy, PGY2 Ambulatory Care, PGY2 Critical Care, PGY2 Emergency Medicine, PGY2 Infections Diseases, and PGY2 Health-System Pharmacy Administration and Leadership.
Beaumont, Royal Oak opened on Jan. 24, 1955 as a 238-bed community hospital. Today, the hospital is a 1,131-bed major academic and referral center with Level I adult trauma and Level II pediatric trauma designation. Beaumont, Royal Oak has 44 residency and fellowship programs with 481 residents and fellows. Beaumont is the exclusive clinical partner of the Oakland University William Beaumont School of Medicine, with more than 1,400 Beaumont doctors on faculty.
Services include in part:
- Beaumont Cancer Institute,
- Proton Therapy Center for Adult and Pediatric Tumors
- Beaumont Children’s including 80 Pediatric Subspecialties and Board-Certified Pediatricians
- Emergency Care
- Newborn and Pediatric Intensive Care
- Cardiac Catheterization and Interventional Cardiology
- Women’s Health
- Beaumont Heart Center – Featuring the Ernst Cardiovascular Center and Max and Debra Ernst Heart Center with specialty clinics
- Beaumont Orthopedics
- Beaumont Cancer Institute
- Beaumont Surgical Services
- Beaumont Urology
- Beaumont Neuroscience
- Digestive Health – specialized care including bariatric surgery and medically-supervised weight loss program...s.
- Eye Institute
The Beaumont Hospital, Royal Oak Department of Pharmaceutical Services utilizes an integrative practice model where pharmacists have responsibilities for both distributive and clinical functions. Distributive services are provided through a centralized model, with satellites in critical areas (pediatrics, OR, and Emergency). Pharmacy operations are supported by technology including carousels and automated dispensing cabinets. The electronic health record is supported by Epic oneChart, with implemented electronic Medication Administration Record and Barcode Medication Administration functionality.
The Beaumont Hospital, Royal Oak Department of Pharmacy has 7 pharmacy residency programs as follows: PGY1 Pharmacy, PGY1 Non-traditional Pharmacy, PGY2 Ambulatory Care, PGY2 Critical Care, PGY2 Emergency Medicine, PGY2 Infections Diseases, and PGY2 Health-System Pharmacy Administration and Leadership.